Literature DB >> 33764430

β-Hemoglobinopathies lead the way.

Yogen Saunthararajah1.   

Abstract

Year:  2021        PMID： 33764430      PMCID： PMC7995288          DOI： 10.1182/blood.2020009961

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Control of globin gene expression during development and erythroid differentiation.

Authors:  George Stamatoyannopoulos
Journal:  Exp Hematol       Date:  2005-03       Impact factor: 3.084

2.  Sickle cell anemia a molecular disease.

Authors:  L PAULING; H A ITANO
Journal:  Science       Date:  1949-11-25       Impact factor: 47.728

3.  Erythroid phenotypes associated with KLF1 mutations.

Authors:  Joseph Borg; George P Patrinos; Alex E Felice; Sjaak Philipsen
Journal:  Haematologica       Date:  2011-05       Impact factor: 9.941

Review 4.  Ultimate Precision: Targeting Cancer but Not Normal Self-replication.

Authors:  Vamsidhar Velcheti; David Schrump; Yogen Saunthararajah
Journal:  Am Soc Clin Oncol Educ Book       Date:  2018-05-23

5.  An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.

Authors:  Daniel E Bauer; Sophia C Kamran; Samuel Lessard; Jian Xu; Yuko Fujiwara; Carrie Lin; Zhen Shao; Matthew C Canver; Elenoe C Smith; Luca Pinello; Peter J Sabo; Jeff Vierstra; Richard A Voit; Guo-Cheng Yuan; Matthew H Porteus; John A Stamatoyannopoulos; Guillaume Lettre; Stuart H Orkin
Journal:  Science       Date:  2013-10-11       Impact factor: 47.728

Review 6.  Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.

Authors:  Swee Lay Thein
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the γ-globin gene in β-thalassemia.

Authors:  Yi Gong; Xinhua Zhang; Qianqian Zhang; Yanxia Zhang; Yuhua Ye; Wenxia Yu; Congwen Shao; Tizhen Yan; Jin Huang; Jianmei Zhong; Li Wang; Yaoyun Li; Liren Wang; Xiangmin Xu
Journal:  Blood       Date:  2021-03-25       Impact factor: 22.113

8.  In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor.

Authors:  Aidan G Gilmartin; Arthur Groy; Elizabeth R Gore; Charity Atkins; Edward R Long; Monica N Montoute; Zining Wu; Wendy Halsey; Dean E McNulty; Daniela Ennulat; Lourdes Rueda; Melissa Pappalardi; Ryan G Kruger; Michael T McCabe; Ali Raoof; Roger Butlin; Alexandra Stowell; Mark Cockerill; Ian Waddell; Donald Ogilvie; Juan Luengo; Allan Jordan; Andrew B Benowitz
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

Review 9.  Allosteric control of mammalian DNA methyltransferases - a new regulatory paradigm.

Authors:  Albert Jeltsch; Renata Z Jurkowska
Journal:  Nucleic Acids Res       Date:  2016-08-12       Impact factor: 16.971

10.  Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

Authors:  Robert Molokie; Donald Lavelle; Michel Gowhari; Michael Pacini; Lani Krauz; Johara Hassan; Vinzon Ibanez; Maria A Ruiz; Kwok Peng Ng; Philip Woost; Tomas Radivoyevitch; Daisy Pacelli; Sherry Fada; Matthew Rump; Matthew Hsieh; John F Tisdale; James Jacobberger; Mitch Phelps; James Douglas Engel; Santhosh Saraf; Lewis L Hsu; Victor Gordeuk; Joseph DeSimone; Yogen Saunthararajah
Journal:  PLoS Med       Date:  2017-09-07       Impact factor: 11.069
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.